Clinical Obesity
Weight Reduction Heterogenicity and Mediators of GLP-1RAs and Dual Agonists for Individuals With Obesity: A Meta-Analysis
ReviewInterventions
The paper
Peking University First Hospital
Clinical Obesity, 14 Sep 2026
Related
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes